A Pilot Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)

Englewood Hospital and Medical Center1 site in 1 country14 target enrollmentOctober 18, 2019

ConditionsNeonatal Respiratory Distress

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Neonatal Respiratory Distress
Sponsor: Englewood Hospital and Medical Center
Enrollment: 14
Locations: 1
Primary Endpoint: Bi-PAP
Status: Terminated
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will explore the RAM Nasal Cannula as a means of providing CPAP and Bi-PAP to infants 28-42 weeks gestation to prevent nasal septal erosion.

Registry

clinicaltrials.gov

Start Date

October 18, 2019

End Date

July 8, 2021

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Englewood Hospital and Medical Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Bi-PAP

Time Frame: 5 days

The study will determine if the RAM Nasal Cannula is providing adequate Bi-PAP to neonates. This will be measured with Pulse Oximetry Level every 3 hours. The pulse oximetry is measured in millimeters

NCPAP

Time Frame: 5 days

The study will determine if the RAM Nasal Cannula is providing adequate CPAP to neonates. This will be measured with Pulse Oximetry Level every 3 hours. The pulse oximetry is measured in millimeters